“It is my honor to steer a corporation devoted to enhancing the well-being of individuals and animals,” he mentioned.
Legg held numerous business management roles in Boehringer Ingelheim’s Human Pharmaceutical division earlier than transferring to the corporate’s Animal Well being enterprise in 2019 to steer the U.S. Pets Business workforce. He’s primarily based on the U.S. headquarters of Boehringer Ingelheim Animal Well being in Duluth, Ga.
Hoekstra retired after holding quite a lot of management roles at Boehringer Ingelheim. As president of Boehringer Ingelheim Animal Well being within the U.S. for the final two years, he oversaw the ultimate integration actions after Boehringer Ingelheim acquired Merial in 2017 to develop into the world’s second-largest animal well being firm.
Boehringer Ingelheim Animal Well being is also transitioning a key international manufacturing function from its international headquarters in Ingelheim, Germany, to america. The corporate has named Dr. Helmut Finkler as Head of Regional Bio Manufacturing Americas & World Manufacturing Science & Expertise. He’ll oversee vaccine-production websites within the Americas, together with in Athens, Ga., Gainesville, Ga., St. Joseph, Mo., and Guadalajara, Mexico. Finkler most lately served as Head of World BIO Operations in World Operations Animal Well being.
Legg and Finkler report back to Jean-Michel Boers, President and CEO of Boehringer Ingelheim USA Corp. He oversees Boehringer Ingelheim’s three enterprise items in america: Human Prescription drugs, Animal Well being and Bio-Pharmaceutical Contract Manufacturing.
About Boehringer Ingelheim Animal Well being
The lives of animals and people are interconnected in deep and complicated methods. We all know that when animals are wholesome, people are more healthy too. Throughout the globe, our 10,000 staff are devoted to delivering worth via innovation, thus enhancing the well-being of each.
Respect for animals, people and the surroundings is on the coronary heart of what we do. We develop options and supply providers to guard animals from illness and ache. We help our clients in taking good care of the well being of their animals and shield our communities towards life- and society- threatening ailments.
Boehringer Ingelheim Animal Well being is the second largest animal well being enterprise on the planet, with internet gross sales of $4.5 billion (4 billion euros) in 2019 and a presence in additional than 150 international locations.
Boehringer Ingelheim Animal Well being has a big presence in america, with greater than 3,100 staff in locations that embrace Georgia, Missouri, Iowa, Minnesota, New Jersey and Puerto Rico. To study extra, go to www.boehringer-ingelheim.us, www.facebook.com/BoehringerAHUS or www.twitter.com/Boehringer_AH.
About Boehringer Ingelheim
Making new and higher medicines for people and animals is on the coronary heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim has been impartial and family-owned. We’ve got the liberty to pursue our long-term imaginative and prescient, waiting for establish the well being challenges of the longer term and concentrating on these areas of want the place we will do the most good.
As a world-leading, research-driven pharmaceutical firm, greater than 51,000 staff create worth via innovation day by day for our three enterprise areas: Human Pharma, Animal Well being, and Biopharmaceutical Contract Manufacturing.
In 2019, Boehringer Ingelheim achieved internet gross sales of $21.3 billion (19 billion euros). Our important funding of over $3.9 billion (3.5 billion euros) in R&D drives innovation, enabling the following technology of medicines that save lives and enhance high quality of life.
We notice extra scientific alternatives by embracing the ability of partnership and variety of specialists throughout the life-science group. By working collectively, we speed up the supply of the following medical breakthrough that may remodel the lives of sufferers now, and in generations to return.
SOURCE Boehringer Ingelheim, Inc.